Cargando…

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

BACKGROUND: Proliferation may predict response to neoadjuvant therapy of breast cancer and is commonly assessed by manual scoring of slides stained by immunohistochemistry (IHC) for Ki-67 similar to ER and PgR. This method carries significant intra- and inter-observer variability. Automatic scoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinn, Hans-Peter, Schneeweiss, Andreas, Keller, Marius, Schlombs, Kornelia, Laible, Mark, Seitz, Julia, Lakis, Sotirios, Veltrup, Elke, Altevogt, Peter, Eidt, Sebastian, Wirtz, Ralph M., Marmé, Frederik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307758/
https://www.ncbi.nlm.nih.gov/pubmed/28193205
http://dx.doi.org/10.1186/s12885-017-3111-1
_version_ 1782507425674297344
author Sinn, Hans-Peter
Schneeweiss, Andreas
Keller, Marius
Schlombs, Kornelia
Laible, Mark
Seitz, Julia
Lakis, Sotirios
Veltrup, Elke
Altevogt, Peter
Eidt, Sebastian
Wirtz, Ralph M.
Marmé, Frederik
author_facet Sinn, Hans-Peter
Schneeweiss, Andreas
Keller, Marius
Schlombs, Kornelia
Laible, Mark
Seitz, Julia
Lakis, Sotirios
Veltrup, Elke
Altevogt, Peter
Eidt, Sebastian
Wirtz, Ralph M.
Marmé, Frederik
author_sort Sinn, Hans-Peter
collection PubMed
description BACKGROUND: Proliferation may predict response to neoadjuvant therapy of breast cancer and is commonly assessed by manual scoring of slides stained by immunohistochemistry (IHC) for Ki-67 similar to ER and PgR. This method carries significant intra- and inter-observer variability. Automatic scoring of Ki-67 with digital image analysis (qIHC) or assessment of MKI67 gene expression with RT-qPCR may improve diagnostic accuracy. METHODS: Ki-67 IHC visual assessment was compared to the IHC nuclear tool (AperioTM) on core biopsies from a randomized neoadjuvant clinical trial. Expression of ESR1, PGR and MKI67 by RT-qPCR was performed on RNA extracted from the same formalin-fixed paraffin-embedded tissue. Concordance between the three methods (vIHC, qIHC and RT-qPCR) was assessed for all 3 markers. The potential of Ki-67 IHC and RT-qPCR to predict pathological complete response (pCR) was evaluated using ROC analysis and non-parametric Mann-Whitney Test. RESULTS: Correlation between methods (qIHC versus RT-qPCR) was high for ER and PgR (spearman´s r = 0.82, p < 0.0001 and r = 0.86, p < 0.0001, respectively) resulting in high levels of concordance using predefined cut-offs. When comparing qIHC of ER and PgR with RT-qPCR of ESR1 and PGR the overall agreement was 96.6 and 91.4%, respectively, while overall agreement of visual IHC with RT-qPCR was slightly lower for ER/ESR1 and PR/PGR (91.2 and 92.9%, respectively). In contrast, only a moderate correlation was observed between qIHC and RT-qPCR continuous data for Ki-67/MKI67 (Spearman’s r = 0.50, p = 0.0001). Up to now no predictive cut-off for Ki-67 assessment by IHC has been established to predict response to neoadjuvant chemotherapy. Setting the desired sensitivity at 100%, specificity for the prediction of pCR (ypT0ypN0) was significantly higher for mRNA than for protein (68.9% vs. 22.2%). Moreover, the proliferation levels in patients achieving a pCR versus not differed significantly using MKI67 RNA expression (Mann-Whitney p = 0.002), but not with qIHC of Ki-67 (Mann-Whitney p = 0.097) or vIHC of Ki-67 (p = 0.131). CONCLUSION: Digital image analysis can successfully be implemented for assessing ER, PR and Ki-67. IHC for ER and PR reveals high concordance with RT-qPCR. However, RT-qPCR displays a broader dynamic range and higher sensitivity than IHC. Moreover, correlation between Ki-67 qIHC and RT-qPCR is only moderate and RT-qPCR with MammaTyper® outperforms qIHC in predicting pCR. Both methods yield improvements to error-prone manual scoring of Ki-67. However, RT-qPCR was significantly more specific. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3111-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5307758
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53077582017-02-22 Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer Sinn, Hans-Peter Schneeweiss, Andreas Keller, Marius Schlombs, Kornelia Laible, Mark Seitz, Julia Lakis, Sotirios Veltrup, Elke Altevogt, Peter Eidt, Sebastian Wirtz, Ralph M. Marmé, Frederik BMC Cancer Research Article BACKGROUND: Proliferation may predict response to neoadjuvant therapy of breast cancer and is commonly assessed by manual scoring of slides stained by immunohistochemistry (IHC) for Ki-67 similar to ER and PgR. This method carries significant intra- and inter-observer variability. Automatic scoring of Ki-67 with digital image analysis (qIHC) or assessment of MKI67 gene expression with RT-qPCR may improve diagnostic accuracy. METHODS: Ki-67 IHC visual assessment was compared to the IHC nuclear tool (AperioTM) on core biopsies from a randomized neoadjuvant clinical trial. Expression of ESR1, PGR and MKI67 by RT-qPCR was performed on RNA extracted from the same formalin-fixed paraffin-embedded tissue. Concordance between the three methods (vIHC, qIHC and RT-qPCR) was assessed for all 3 markers. The potential of Ki-67 IHC and RT-qPCR to predict pathological complete response (pCR) was evaluated using ROC analysis and non-parametric Mann-Whitney Test. RESULTS: Correlation between methods (qIHC versus RT-qPCR) was high for ER and PgR (spearman´s r = 0.82, p < 0.0001 and r = 0.86, p < 0.0001, respectively) resulting in high levels of concordance using predefined cut-offs. When comparing qIHC of ER and PgR with RT-qPCR of ESR1 and PGR the overall agreement was 96.6 and 91.4%, respectively, while overall agreement of visual IHC with RT-qPCR was slightly lower for ER/ESR1 and PR/PGR (91.2 and 92.9%, respectively). In contrast, only a moderate correlation was observed between qIHC and RT-qPCR continuous data for Ki-67/MKI67 (Spearman’s r = 0.50, p = 0.0001). Up to now no predictive cut-off for Ki-67 assessment by IHC has been established to predict response to neoadjuvant chemotherapy. Setting the desired sensitivity at 100%, specificity for the prediction of pCR (ypT0ypN0) was significantly higher for mRNA than for protein (68.9% vs. 22.2%). Moreover, the proliferation levels in patients achieving a pCR versus not differed significantly using MKI67 RNA expression (Mann-Whitney p = 0.002), but not with qIHC of Ki-67 (Mann-Whitney p = 0.097) or vIHC of Ki-67 (p = 0.131). CONCLUSION: Digital image analysis can successfully be implemented for assessing ER, PR and Ki-67. IHC for ER and PR reveals high concordance with RT-qPCR. However, RT-qPCR displays a broader dynamic range and higher sensitivity than IHC. Moreover, correlation between Ki-67 qIHC and RT-qPCR is only moderate and RT-qPCR with MammaTyper® outperforms qIHC in predicting pCR. Both methods yield improvements to error-prone manual scoring of Ki-67. However, RT-qPCR was significantly more specific. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3111-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-13 /pmc/articles/PMC5307758/ /pubmed/28193205 http://dx.doi.org/10.1186/s12885-017-3111-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sinn, Hans-Peter
Schneeweiss, Andreas
Keller, Marius
Schlombs, Kornelia
Laible, Mark
Seitz, Julia
Lakis, Sotirios
Veltrup, Elke
Altevogt, Peter
Eidt, Sebastian
Wirtz, Ralph M.
Marmé, Frederik
Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title_full Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title_fullStr Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title_full_unstemmed Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title_short Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer
title_sort comparison of immunohistochemistry with pcr for assessment of er, pr, and ki-67 and prediction of pathological complete response in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307758/
https://www.ncbi.nlm.nih.gov/pubmed/28193205
http://dx.doi.org/10.1186/s12885-017-3111-1
work_keys_str_mv AT sinnhanspeter comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT schneeweissandreas comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT kellermarius comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT schlombskornelia comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT laiblemark comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT seitzjulia comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT lakissotirios comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT veltrupelke comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT altevogtpeter comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT eidtsebastian comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT wirtzralphm comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer
AT marmefrederik comparisonofimmunohistochemistrywithpcrforassessmentoferprandki67andpredictionofpathologicalcompleteresponseinbreastcancer